Silver nanoparticles/chitosan oligosaccharide/poly(vinyl alcohol) nanofiber promotes wound healing by activating TGFβ1/Smad signaling pathway

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 373-387

  Li, Chen Wen ^a   Wang, Qing ^b   Li, Jing ^c   Hu, Min ^a   Shi, San Jun ^a   Li, Zi Wei ^a   Wu, Guo Lin ^a   Cui, Huan Huan ^a   Li, Yuan Yuan ^a   Zhang, Qian ^a   Yu, Xiu Heng ^b   Lu, Lai Chun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c QINGDAO UNIVERSITY   (China)

Author keywords

Electrospinning; Nanofiber; Silver nanoparticles; Smad proteins; TGF 1; Wound healing

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CHITOSAN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; NANOFIBER; POLYVINYL ALCOHOL; RNA; SILVER NANOPARTICLE; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; MESSENGER RNA; METAL NANOPARTICLE; SILVER; SMAD PROTEIN; TGFB1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN FIBER; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GAUZE DRESSING; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKIN BIOPSY; SKIN INJURY; SKIN ULCER; THERAPY EFFECT; TISSUE REGENERATION; UPREGULATION; WOUND CONTRACTION; WOUND HEALING; ANIMAL; BANDAGE; CHEMISTRY; DRUG EFFECTS; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BANDAGES; BLOTTING, WESTERN; CHITOSAN; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOENZYME TECHNIQUES; MALE; METAL NANOPARTICLES; NANOFIBERS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SILVER; SKIN; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84955285900     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S91975     Document Type: Article

References (48)

1. Wu Z, Tang Y, Fang H, et al. Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds. J Mater Sci. 2015;26:1–10.
2. Delavary BM, van der Veer WM, van Egmond M, et al. Macrophages in skin injury and repair. Immunobiology. 2011;216:753–762.
3. Pereira RF, Barrias CC, Granja PL, et al. Advanced biofabrication strategies for skin regeneration and repair. Nanomedicine. 2013;8:603–621.
4. Sandeep K, Maiti SK, Naveen K, et al. Effect of medical grade chitosan powder in full thickness skin wound healing in rat model. J Anim Vet Adv. 2014;2:270–276.
5. Rieger KA, Birch NP, Schiffman JD. Designing electrospun nanofiber mats to promote wound healing – a review. J Mater Chem B. 2013;1:4531–4541.
6. Zahedi P, Rezaeian I, Ranaei-Siadat SO, et al. A review on wound dressings with an emphasis on electrospun nanofibrous polymeric bandages. Polym Adv Technol. 2010;21:77–95.
7. Muzzarelli RAA, Muzzarelli C. Chitosan chemistry: relevance to the biomedical sciences. Adv Polym Sci. 2005;151–209.
8. Liu X, Xia W, Jiang Q, et al. Effect of kojic acid-grafted-chitosan oligosaccharides as a novel antibacterial agent on cell membrane of gram-positive and gram-negative bacteria. J Biosci Bioeng. 2015;120(3):335–339.
9. Xia W, Liu P, Zhang J, et al. Biological activities of chitosan and chitooligosaccharides. Food Hydrocolloids. 2011;25:170–179.
10. Liu X, Xia W, Jiang Q, et al. Synthesis, characterization, and antimicrobial activity of kojic acid grafted chitosan oligosaccharide. J Agric Food Chem. 2013;62:297–303.
11. Li C, Fu R, Yu C, et al. Silver nanoparticle/chitosan oligosaccharide/poly(vinyl alcohol) nanofibers as wound dressings: a preclinical study. Int J Nanomed. 2013;8:4131.
12. Li L, Zhu Z, Xiao W. Multi-walled carbon nanotubes promote cementoblast differentiation and mineralization through the TGF-β/Smad signaling pathway. Int J Mol Sci. 2015;16:3188–3201.
13. Cichon MA, Radisky DC. Extracellular matrix as a contextual determinant of transforming growth factor-b signaling in epithelial-mesenchymal transition and in cancer. Cell Adhes Migrat. 2014;8(6):588–594.
14. Leask A. New insights into the basis of the activated fibroblast phenotype in scleroderma. Adv Skin Wound Care. 2011;2:210–216.
15. Tang B, Zhu B, Liang Y, et al. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts. Arch Dermatol Res. 2011;303:563–572.
16. Ganeshkumar M, Ponrasu T, Krithika R, et al. Topical application of Acalypha indica accelerates rat cutaneous wound healing by up-regulating the expression of Type I and III collagen. J Ethnopharmacol. 2012;142:14–22.
17. Verrecchia F, Mauviel A. Control of connective tissue gene expression by TGFβ: role of Smad proteins in fibrosis. Curr Rheumatol Rep. 2002;4:143–149.
18. Hu PP-C, Datto MB, Wang X-F. Molecular mechanisms of transforming growth factor-β signaling. Endocr Rev. 1998;19:349–363.
19. Itoh S, Itoh F, Goumans MJ, et al. Signaling of transforming growth factor-β family members through Smad proteins. Eur J Biochem. 2000;267:6954–6967.
20. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–289.
21. Bhawal UK, Lee H-J, Uchida R, et al. The pro-healing effect of protamine-hydrolysate peptides on skin wounds involves TGF-β/Smad signaling. J Hard Tissue Biol. 2015;24:91–98.
22. Shi H-X, Lin C, Lin B-B, et al. The anti-scar effects of basic fibroblast growth factor on the wound repair in vitro and in vivo. PloS One. 2013;8:e59966.
23. Inman GJ, Nicolás FJ, Callahan JF, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65–74.
24. Shivananda BN, Vincent R, Sandeep M, et al. Wound healing activity of the fruit skin of Punica granatum. J Med Food. 2013;16:857–861.
25. Oxlund H, Christensen H, Seyer-Hansen M, et al. Collagen deposition and mechanical strength of colon anastomoses and skin incisional wounds of rats. J Surg Res. 1996;66:25–30.
26. Dorsett-Martin WA. Rat models of skin wound healing: a review. Wound Repair Regen. 2004;12:591–599.
27. Pang Y, Wang D, Hu X, et al. Effect of volatile oil from Blumea Balsamifera (L.) DC. leaves on wound healing in mice. J Tradit Chin Med. 2014;34:716–724.
28. Rosensteel SM, Wilson RP, White SL, et al. COL1A1 oligodeoxynucleotides decoy: biochemical and morphologic effects in an acute wound repair model. Exp Mol Pathol. 2010;89:307–313.
29. Ud-Din S, Sebastian A, Giddings P, et al. Angiogenesis is induced and wound size is reduced by electrical stimulation in an acute wound healing model in human skin. PloS One. 2015;10:1–22.
30. Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37:1528–1542.
31. Boateng JS, Matthews KH, Stevens HN, et al. Wound healing dressings and drug delivery systems: a review. J Pharm Sci. 2008;97:2892–2923.
32. Laping N, Grygielko E, Mathur A, et al. Inhibition of transforming growth factor (TGF)-β1–induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542. Mol Pharmacol. 2002;62:58–64.
33. Halder SK, Beauchamp RD, Datta PK. A specific inhibitor of TGF-β receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia. 2005;7:509–521.
34. Sakai H, Matsuura K, Tanaka Y, et al. Signaling mechanism underlying the promotion of keratinocyte migration by angiotensin II. Mol Pharmacol. 2015;87:277–285.
35. Sugiyama K, Ishii G, Ochiai A, et al. Improvement of the breaking strength of wound by combined treatment with recombinant human G-CSF, recombinant human M-CSF, and a TGF-β1 receptor kinase inhibitor in rat skin. Cancer Sci. 2008;99:1021–1028.
36. Maquart F, Monboisse J. Extracellular matrix and wound healing. Pathol Biol. 2014;62:91–95.
37. Yamaoka H, Sumiyoshi H, Higashi K, et al. A novel small compound accelerates dermal wound healing by modifying infiltration, proliferation and migration of distinct cellular components in mice. J Dermatol Sci. 2014;74:204–213.
38. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow–derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004:22:812–822.
39. Verrecchia F, Chu M-L, Mauviel A. Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem. 2001;276:17058–17062.
40. Schiller M, Javelaud D, Mauviel A. TGF-β-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 2004;35:83–92.
41. Martin P. Wound healing – aiming for perfect skin regeneration. Science. 1997;276:75–81.
42. Beldon P. Basic science of wound healing. Surgery (Oxford). 2010;28:409–412.
43. Heldin C-H, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465–471.
44. Xu L, Zheng N, He Q, et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. Phytomedicine. 2013;20:1172–1179.
45. Reynolds LE, Conti FJ, Silva R, et al. α3β1 integrin–controlled Smad7 regulates reepithelialization during wound healing in mice. J Clin Invest. 2008;118:965.
46. Takagawa S, Lakos G, Mori Y, et al. Sustained activation of fibroblast transforming growth factor-β/Smad signaling in a murine model of scleroderma. J Invest Ddermatol. 2003;121:41–50.
47. Miyazono K, Ten Dijke P, Heldin C-H. TGF-β signaling by Smad proteins. Adv Immunol. 2000;75:115–157.
48. Lee K-B, Jeon J-H, Choi I, et al. Clusterin, a novel modulator of TGF-β signaling, is involved in Smad2/3 stability. Biochem Biophy Res Commun. 2008;366:905–909.